Rapport Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:RAPP Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
31 Dec 25	SellUS$85,342	Swamy Yeleswaram	Individual	2,840	US$30.05
31 Dec 25	SellUS$197,338	David Bredt	Individual	6,567	US$30.05
12 Sep 25	BuyUS$499,374	Reid Huber	Individual	20,400	US$24.48
12 Sep 25	BuyUS$1,027,111	Steven Paul	Individual	41,666	US$24.97
11 Sep 25	BuyUS$79,100	Wendy Young	Individual	3,500	US$22.60
13 Mar 25	BuyUS$100,988	Troy Ignelzi	Individual	10,000	US$10.10
12 Mar 25	BuyUS$61,250	Wendy Young	Individual	6,000	US$10.21

Insider Trading Volume

Insider Buying: RAPP insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of RAPP?
Owner Type	Number of Shares	Ownership Percentage
State or Government	5,400	0.0102%
Individual Insiders	2,195,576	4.16%
Hedge Funds	3,192,521	6.05%
VC/PE Firms	11,833,189	22.4%
Institutions	35,539,182	67.4%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 30.3%.

Top Shareholders

Top 25 shareholders own 99.31% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
17%	Third Rock Ventures, LLC	8,104,451	US$222.4m	0%	27.02%
14.5%	FMR LLC	6,916,995	US$189.8m	26.4%	0.01%
7.82%	Arch Venture Partners, L.P.	3,728,738	US$102.3m	0%	8.04%
7.14%	Capital Research and Management Company	3,402,529	US$93.4m	30.7%	no data
6.7%	Cormorant Asset Management, LP	3,192,521	US$87.6m	8.56%	4.45%
5.03%	BlackRock, Inc.	2,397,549	US$65.8m	52.9%	no data
4.09%	Sofinnova Investment, Inc.	1,947,579	US$53.4m	-2.41%	2.46%
3.81%	The Vanguard Group, Inc.	1,817,757	US$49.9m	11.8%	no data
3.8%	T. Rowe Price Group, Inc.	1,809,899	US$49.7m	-15.4%	no data
3.74%	Johnson & Johnson Innovation - JJDC, Inc.	1,784,517	US$49.0m	-28.6%	9.03%
3.43%	The Goldman Sachs Group, Inc.	1,632,469	US$44.8m	0%	0.02%
3.25%	Baker Bros. Advisors LP	1,547,090	US$42.5m	181%	0.23%
2.35%	UBS Asset Management AG	1,118,618	US$30.7m	-22.9%	no data
2.21%	Artal Group S.A.	1,053,469	US$28.9m	178%	0.58%
1.99%	Vestal Point Capital, LP	950,000	US$26.1m	0%	0.98%
1.97%	Polar Capital Holdings Plc	938,952	US$25.8m	0%	0.07%
1.8%	AllianceBernstein L.P.	855,620	US$23.5m	-25.9%	0.01%
1.66%	Goldman Sachs Asset Management, L.P.	789,507	US$21.7m	-19.5%	no data
1.4%	Abraham Ceesay	669,621	US$18.4m	-6.12%	no data
1.12%	Geode Capital Management, LLC	533,403	US$14.6m	60.1%	no data
1.09%	Steven Paul	519,308	US$14.2m	8.72%	no data
0.94%	Adage Capital Management, L.P.	450,000	US$12.3m	0%	0.02%
0.85%	Perceptive Advisors LLC	403,923	US$11.1m	0%	0.25%
0.83%	David Bredt	395,575	US$10.9m	-5.4%	no data
0.78%	State Street Global Advisors, Inc.	371,626	US$10.2m	24.4%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/02/04 00:30
End of Day Share Price	2026/02/04 00:00
Earnings	2025/09/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Rapport Therapeutics, Inc. is covered by 11 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Kambiz Yazdi	BTIG
Jason Butler	Citizens JMP Securities, LLC
Salveen Richter	Goldman Sachs